Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Sleeve cover may help keep vital IV lines in place

NCT ID NCT07817732

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time

Summary

Researchers are testing a new sleeve cover designed to protect peripherally inserted central catheters (PICCs) and prevent them from slipping out. The pilot trial enrolls adult hospital patients who need a PICC for various medical conditions. Participants are randomly assigned to either use the sleeve cover along with standard securement or receive standard securement alone. The study measures how many patients can be recruited, how well they tolerate the sleeve, and whether it affects the line's condition.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A protective sleeve cover worn over a PICC line
What this could lead to
If the sleeve proves feasible and safe, it could become a simple way to help keep PICC lines secure and reduce the need for replacements.
What could go wrong
This is a small pilot study focused on feasibility, not a definitive test of whether the sleeve prevents dislodgement. The results may not show a clear benefit, and the sleeve could cause skin irritation or be uncomfortable for some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

67 people

The number who actually took part.

Started

Mar 2024

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients receiving PICC placement for various medical conditions Exclusion Criteria: * Patients with known allergies to materials in the PICC sleeve * Patients contraindicated for PICC placement * Patients who are aggressive and/or restless * Patients whose skin condition is unsuitable for CHG gel dressing application (e.g. skin with eczema plaques, bullous pemphigoid) * Patients who have no mental capacity to give consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Patient with picc lines are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Changi General Hospital

    Singapore, 529889, Singapore